PhytoNexus

PhytoNexus

Department of Pharmacognosy · Herb-Drug Interaction Intelligence Platform · generated 27 Jul 2026 02:06 IST
Cucurbitaceae · source entry 106

Momordica charantia

Karela (Bitter gourd)

Tier 2 · Verified 0 curated · 0 predicted Risk index 0
PATIENT CHARACTERISTIC - G6PD DEFICIENCY (FAVISM-LIKE HAEMOLYSIS

01 Identity and provenance

Accepted binomial
Momordica charantia
Common names
Karela (Bitter gourd)
Family (APG IV)
Cucurbitaceae
Part used
Fruit
Verification tier
Tier 2 · Verified Clinical columns reviewed and a source is on record.
Reviewer note (2026 audit)
LiverTox NBK590483 | Meta-analysis: PMC10808600 | VERIFIED 2026 - synthetic analogue, application, interactions, side effects and references populated from retrieved primary/regulatory sources (see References). Interaction entries are labelled CLINICAL (case reports or trials in humans) vs THEORETICAL (in-vitro or animal only). Marketed-formulation column intentionally left blank. | HOST FACTOR

02 Constituent chemistry

Chemical classMarker compoundSynthetic analogue in use
Cucurbitane triterpenoids Charantin
Fruit
Metformin, insulin secretagogues (FUNCTIONAL only). No structural analogue.

The analogue column is what makes the interaction reasoning tractable: where a constituent has a marketed structural counterpart, the counterpart's interaction profile is the starting hypothesis for the plant.

Looking up structures and physicochemical properties from PubChem…

03 Stated application

Reported activity
Traditionally used as a glucose-lowering agent in T2DM and prediabetes. IMPORTANT: 2024 meta-analysis of 9 RCTs (n=414) found NO significant effect on fasting glucose or HbA1c versus placebo. Efficacy is not established.
Reported adverse effects
Hypoglycaemic coma and convulsions reported in children after leaf tea. Favism-like haemolytic anaemia in G6PD deficiency (vicine in seeds) - RELEVANT IN SOUTH ASIAN POPULATIONS. Also GI upset, diarrhoea, abdominal pain, headache; one case of haematemesis after concentrated extract.

04 Interaction matrix

Source column, verbatim: CLINICAL: additive effect with any glucose-lowering agent.
Normalised onto 0 canonical drug classes below.

No interaction edges recorded, and the constituent chemistry did not trigger any rule. That is an absence of data, not evidence of safety.

05 Hazard register

patient characteristic - G6PD deficiency (favism-like haemolysis

06 Confusable material

These entries could be mistaken for this one in trade, in the herbarium, or in a prescription. Powdered material is often indistinguishable, so the check is macroscopic, microscopic and chromatographic rather than nominal.

Citrus aurantium
Bitter Orange
Rutaceae Shares the common name "bitter"

07 Mechanism map

Chemistry sorts to the left, pharmacology to the right. Dashed edges are predicted. Drag nodes, scroll to zoom, export at 3× for a figure.

species
chemical class
marker compound
drug class
expected effect
hazard

08 Open literature

Abstract-scoped query built from this binomial, its common names and its marker compounds, run live against Europe PMC, PubMed and OpenAlex, then ranked locally against an evidence hierarchy.

Checking openFDA spontaneous reports…

09 Isomechanistic neighbours

No overlapping interaction profile in the corpus.

10 References and notes

Source column: Basch E et al. Am J Health Syst Pharm 2003;60:356-9

Basch E et al. Am J Health Syst Pharm 2003

Basch E et al. Am J Health Syst Pharm 2003 manual

60:356-9

manual
BibTeX for all 2 records
@article{BaschEeta2003,
  title = {Basch E et al. Am J Health Syst Pharm 2003},
  author = {Basch E et al.},
  journal = {Am J Health Syst Pharm},
  year = {2003},
}

@article{anon,
  title = {60:356-9},
}

Curator notes

No notes yet.

Sign in to add notes and save monographs.